Connective Capital Management’s Medicus Pharma Warrant MDCXW Stock Holding History

Connective Capital Management’s Portfolio MDCXW Stock Details MDCXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.9K	Hold	6,000	–	–	﹤0.01%	68
2026 Q1	$3.36K	Hold	6,000	–	–	﹤0.01%	65
2025 Q4	$4.8K	Hold	6,000	–	–	﹤0.01%	55
2025 Q3	$4.32K	Hold	6,000	–	–	﹤0.01%	71
2025 Q2	$5.3K	Hold	6,000	–	–	0.01%	48
2025 Q1	$4.2K	Hold	6,000	–	–	﹤0.01%	43
2024 Q4	$2.11K	Buy	+6,000	New	+$3.84K	﹤0.01%	67

Other funds holding MDCXW

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Connective Capital Management's MDCXW Position: Q2 2026 in Review

Connective Capital Management held its Medicus Pharma Warrant (MDCXW) position steady in Q2 2026 at 6,000 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #68.

Connective Capital Management first reported a position in MDCXW in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.3K in Q2 2025. 4 funds tracked by Wall St. Rank hold MDCXW as of Q2 2026.

Connective Capital Management held 6,000 shares of Medicus Pharma Warrant worth $3.9K as of Q2 2026.
Connective Capital Management left its Medicus Pharma Warrant share count unchanged in Q2 2026.
Medicus Pharma Warrant made up ﹤0.01% of Connective Capital Management's portfolio in Q2 2026, its #68 holding.
Connective Capital Management first reported a position in Medicus Pharma Warrant in Q4 2024 and has held it in 7 quarters since.
Connective Capital Management's Medicus Pharma Warrant position peaked at $5.3K in Q2 2025.
4 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q2 2026.

Based on Connective Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.